Surgery Partners, Inc. (SGRY) Misses Q3 EPS by 6c; reaffirms guidance

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.06 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $770.4 million versus the consensus estimate of $768.99 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2024 revenue of $3.075 billion, versus the consensus of $3.086 billion.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Venu Holding enters $250 million at-the-market stock offering agreement
• 22nd Century Group files prospectus for warrant share resale